News
AbbVie is big pharma’s first mover in ‘in situ’ cell therapy
AbbVie has signed a wide-ranging collaboration with Umoja Biopharma in the area of ‘in situ’ or in vivo cell therapy, an emerging strategy that does away with the need to
